ADHD pathways

Industry
By
Chloe Hava
-

References

  1. Australian Institute of Health and Welfare. ADHD medications dispensed 2004–05 to 2023–24. 2025. At: www.aihw.gov.au/mental-health/topic-areas/community-based-services/mental-health-prescriptions/adhd-medications-dispensed-overtime
  2. Healthdirect. Attention deficit hyperactivity disorder (ADHD). 2025. At: www.healthdirect.gov.au/attention-deficit-disorder-add-or-adhd
  3. Swan N, Ting I, Donaldson A, et al. ADHD rates in adults are skyrocketing — but by how much depends where you live. ABC News. 20 Apr 2026. At: www.abc.net.au/news/2026-04-20/adhd-diagnosis-rates-adults-australia-data-four-corners/106557646
  4. Bruno C, Havard A, Gillies MB, et al. Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: a population-based study among Australian children and adults (2013–2020). Aust N Z J Psychiatry 2023;57(5):675–85.
  5. NSW Health. Reforms to enable GPs to diagnose ADHD from March. 2026. At: www.health.nsw.gov.au/news/Pages/20260211_00.aspx
  6. Commonwealth of Australia, Senate Community Affairs Legislation Committee. Estimates, 11 February 2026 (Penny Shakespeare, p. 81). At: www.aph.gov.au/Parliamentary_Business/Hansard/Hansard_Display?bid=committees/estimate/29370/&sid=0000
  7. Government of Victoria. Urgent ADHD top-up prescriptions even easier and cheaper. 2026. At: www.premier.vic.gov.au/urgent-adhd-top-prescriptions-even-easier-and-cheaper
  8. Rowney-Smith A, Sutton B, Quadt L, et al. The lived experiences of rejection sensitivity in ADHD – a qualitative exploration. PLoS One 2026;21(1):e0314669.
  9. Thomson A, Cairns RF, Magotra H, et al. Exposures to attention deficit hyperactivity disorder medications reported to the New South Wales Poisons Information Centre (2014–2023): a retrospective study. Aust N Z J Psychiatry 2026;60(2):136–47.
  10. Kaur G. Dietary interventions and supplements for managing attention-deficit/hyperactivity disorder (ADHD): a systematic review of efficacy and recommendations. Cureus 2024;16(9):e69804.
  11. ISMP Canada. Alert: clonidine compounding errors continue to harm children. 2023. At: https://ismpcanada.ca/bulletin/alert-clonidine-compounding-errors-continue-to-harm-children/
  12. Barbuto AF, Burns MM. Clonidine compounding error: bradycardia and sedation in a pediatric patient. J Emerg Med 2020;59(1):53–5.
  13. Pharmacy Board of Australia. Compounding error – incorrect strength of ingredient [case study]. 2021. At: www.pharmacyboard.gov.au/News/Professional-Practice-Issues/Case-studies-learnings.aspx
  14. Therapeutic Goods Administration. Clonidine – importance of dosing compliance and safe storage [safety update]. Canberra: TGA. 29 Apr 2021. At: www.tga.gov.au/news/safety-updates/clonidine-importance-dosing-compliance-and-safe-storage
  15. Osianlis E, Thomas EHX, Jenkins LM, et al. ADHD and sex hormones in females: a systematic review. J Atten Disord 2025;29(9):706–23.
  16. Kooij JJS, De Jong M, Agnew-Blais J, et al. Research advances and future directions in female ADHD: the lifelong interplay of hormonal fluctuations with mood, cognition and disease. Front Glob Womens Health 2025;6:1613628.